Microsatellite instability and mismatch repair deficiency in the era of precision immuno-oncology

Expert Rev Anticancer Ther. 2020 Jan;20(1):1-4. doi: 10.1080/14737140.2020.1705789. Epub 2019 Dec 18.

Authors

Steven A Mann¹, Liang Cheng¹

Affiliation

¹ Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

PMID: 31842633
DOI: 10.1080/14737140.2020.1705789

No abstract available

Keywords: Microsatellite instability (MSI); checkpoint inhibition; mismatch repair deficiency; molecular genetics; precision immno-oncology.

Publication types

Editorial

MeSH terms

Antineoplastic Agents, Immunological / administration & dosage*
Antineoplastic Agents, Immunological / pharmacology
Brain Neoplasms / genetics
Colorectal Neoplasms / genetics
DNA Mismatch Repair / genetics
Humans
Microsatellite Instability
Neoplasms / drug therapy*
Neoplasms / genetics
Neoplasms / immunology
Neoplastic Syndromes, Hereditary / genetics
Precision Medicine

Substances

Antineoplastic Agents, Immunological

Supplementary concepts

Turcot syndrome